Europe Regional Office

Welcome to the Europe Regional Office (IERO) in Stockholm, which serves as a dynamic gateway connecting scientific excellence in Europe with global health innovation.

Established in 2023 as the first regional presence of International Vaccine Institute beyond its headquarters in Seoul, Republic of Korea, the office bolsters life science and global health networks in Sweden and Europe, engaging stakeholders across research centers, academia, industry, and government.

IERO expands IVI’s access to European partners, funders, and innovation ecosystems while strengthening collaboration between Europe and the rest of the world in vaccine research, clinical trials, and manufacturing.

The office and projects are supported by funding from the Government of Sweden, and the Swedish International Development Cooperation Agency (Sida).

Background and timeline

1997: Sweden becomes a founding Member State, signing and ratifying the IVI Establishment Agreement to formally support the creation of the organization.

2021: IVI invites proposals for the establishment of IERO. The IVI Board of Trustees selects Stockholm, recognizing Sweden’s world-class research infrastructure, strong commitment to global health, and vibrant life sciences industry.

2022: The Swedish Parliament approves a Host Country Agreement with IVI, laying the foundation for the establishment of the Europe office in Stockholm.

2024: The permanent IVI Europe Regional Office is inaugurated on May 3, 2024, with Swedish government officials, ambassadors, and key partners from IVI’s global network in attendance.

Learn more about IVI and Sweden’s partnership.

Contact

Visiting address: Berzelius väg 8, Stockholm, Sweden
Email: ivieurope@ivi.int